查詢結果分析
來源資料
相關文獻
- Rare Presentation of Prostate Cancer Mimicking Malignant Lymphoma with Generalized Lymphadenopathy
- Flutamide-Induced Liver Injury: A Case Report
- 攝護腺癌之化學藥物治療
- 攝護腺癌的放射線治療及其護理
- Free-to-total Serum Prostate Specific Antigen Ratio in Chinese Men
- 從末期攝護腺癌及乳癌來探討癌症病患荷爾蒙治療法之進展
- Detection of Prostatic Cancer Using Digital Rectal Examination, Prostate-Specific Antigen and Transrectal Ultrasonography
- Use of a Medical Decision Support System to Improve the Preoperative Diagnosis of Prostate Cancer with Pelvic Lymph Node Metastases
- Prostatic Carcinoma Presenting as Rectal Stenosis--A Case Report
- 攝護腺肥大患者之潛伏攝護腺癌
頁籤選單縮合
題名 | Rare Presentation of Prostate Cancer Mimicking Malignant Lymphoma with Generalized Lymphadenopathy=攝護腺癌模仿惡性淋巴癌的表現:以全身性淋巴結腫大為一罕見的表現方式 |
---|---|
作者 | 蔡郁棻; 卓士峯; 吳俊杰; 劉大智; Tsai, Yu-fen; Cho, Shih-feng; Wu, Chun-chieh; Liu, Ta-chih; |
期刊 | 臺灣癌症醫學雜誌 |
出版日期 | 20140600 |
卷期 | 1:1 2014.06[民103.06] |
頁次 | 頁70-74 |
分類號 | 415.863 |
語文 | eng |
關鍵詞 | 攝護腺癌; 全身性淋巴結腫大; 惡性淋巴癌; Prostate cancer; Generalized lymphadenopathy; Malignant lymphoma; |
中文摘要 | 攝護腺癌的轉移大多是以骨頭及局部淋巴結為主。全身性淋巴結腫大在轉移性攝護 腺癌上是非常罕見的。本個案為一位 65 歲診斷攝護腺癌的男性,以全身性淋巴結腫大為 初始表現且沒有任何相關泌尿道症狀。此病人的淋巴結切片報告為轉移性腺癌,其免疫 組織化學染色顯示攝護腺特異抗原為陽性,懷疑原發自攝護腺,最終以攝護腺切片確診 為攝護腺癌。因此,轉移性腺癌在男性一定要考慮攝護腺癌的可能,即便病人是以全身 性淋巴結腫大為表現的情況下,亦不能排除攝護腺癌的可能性。 |
英文摘要 | Prostate cancer typically metastasizes to bones and regional lymph nodes. Generalized lymphadenopathy is a rare manifestation of metastatic prostate cancer. We report a case of prostate cancer in a 65-year-old male with initial presentation of generalized lymphadenopathy and no urinary symptoms. Lymph node biopsy revealed metastatic adenocarcinoma, and immunohistochemical staining was positive for prostate-specific antigen (PSA) compatible with a prostatic origin. Directed biopsy confirmed that the tumor originated in the prostate. Therefore, the prostate should be considered a possible origin of metastatic adenocarcinoma in men, and presentations consistent with generalized lymphadenopathy cannot exclude a diagnosis of prostate cancer. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。